AF
AI accurately detects subtle signs of atrial fibrillation even in normal tests
August 2, 2019Medical Communications AF, AI, ECG, atrial fibrillation, electrcardiogram, pharma
A new study from the Mayo Clinic shows that artificial intelligence (AI) can detect signs of atrial fibrillation (AF) in …
Gamification: what’s in it for the pharma industry?
October 6, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AF, Boehringer, COPD, CRUK, Gamification, ROI, Syrum, digital
Gamification is the new buzzword in digital marketing and has the potential to engage consumers more than traditional strategies. This …
Pradaxa ‘safe’ says Australian regulator
August 6, 2014Research and Development, Sales and Marketing AF, Australia, BMJ, Pradaxa, stroke
Australia’s drug regulator says it will not be updating its safety advice for Boehringer’s Pradaxa despite mounting safety issues around …
Boehringer’s online PMCPA breach
April 25, 2013Medical Communications, Research and Development, Sales and Marketing ABPI, AF, Boehringer, PMCPA
Boehringer Ingelheim has failed to uphold high standards, according to the PMCPA, which enforces the ABPI Code of Practice, over …
Eliquis in UK for AF
December 13, 2012Sales and Marketing AF, BMS, Eliquis, NVAF, Pfizer
Eliquis has been made available in the UK today to prevent stroke and systemic embolism in patients with nonvalvular atrial …
Xarelto gets new EU approval
November 21, 2012Sales and Marketing AF, Bayer, DVT, Xarelto
Bayer’s oral anticoagulant Xarelto has extended its licence in Europe to treat pulmonary embolism (PE) and prevent recurrent deep vein …
Merck gives back vernakalant rights
September 28, 2012Sales and Marketing AF, Cardiome, Merck, vernakalant
Merck has dealt a further blow to Cardiome Pharma Corp by handing back all marketing and development rights for the …
Petition launched to raise AF and stroke awareness
April 20, 2012Business Services, Medical Communications, Sales and Marketing AF, Boehringer Ingelheim, Pradaxa, Xarelto, stroke
Various health organisations have called on more people involved in the management of atrial fibrillation (AF) to help raise awareness …
NICE set to reject Xarelto in AF
January 10, 2012Sales and Marketing AF, NICE, Pradaxa, Xarelto, atrial fibrillation
NICE says it needs more data on Bayer’s Xarelto in order to recommend it for people with atrial fibrillation. The …
Multaq raises risk of death in permanent AF patients
November 16, 2011Sales and Marketing AF, Multaq, Sanofi
More bad news for Sanofi’s Multaq as new data shows the drug doubles the risk of death in people with …
Boehringer agrees Pradaxa kidney function warning
October 30, 2011Sales and Marketing AF, EMA, Pradaxa, renal function
Boehringer Ingelheim is to alert doctors in Europe of the need to check patients’ kidney function before prescribing anticoagulant Pradaxa. …
Companies join forces to promote AF awareness
February 16, 2011Medical Communications, Sales and Marketing AF, Multaq, Pradaxa, apixaban, atrial fibrillation
Boehringer Ingelheim and Sanofi-Aventis are to co-sponsor the World Heart Federation’s global atrial fibrillation (AF) education campaign. AF AWARE was …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
